Bristol-Myers Squibb Company DSO Ratio 2011-2026 | BMY

Annual DSO Ratio Bristol-Myers Squibb Company

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
83.9	81.9	84.4	76.1	70.3	69.5	107	96.5	111	104	94.8	77.9	74.8	63.9	64.3

All numbers in USD currency

Maximum	Minimum	Average
111	63.9	84

2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
82.6	88.9	86.1	81.8	79.8	84.9	82	80.2	-	39.1	32.7	70	-	71.7	68.9	70.7	70.1	73.6	76.6	68.5	88.3	117	112	104	89.5	95.6	95.4	108	106	109	112	110	96.5	103	104	102	91.5	96.4	94.2	86.8	72.7	78.9	79.5	80.8	69	75.4	75.7	76.7	67.1	75.3	63.3	59.3	62.6	63.9	62.9	-

All numbers in USD currency

Maximum	Minimum	Average
117	32.7	82.8

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	2.94 K	-	5743.5 %	$ 69.7 M	Canada
Happiness Biotech Group Limited HAPP	29	-	1.35 %	$ 17.8 M	China
Dynavax Technologies Corporation DVAX	56.5	-	-	$ 2.02 B	USA
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Deciphera Pharmaceuticals DCPH	60.8	-	-	$ 2.18 B	USA
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Alpine Immune Sciences ALPN	1.73	-	-	$ 2.17 B	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
Affimed N.V. AFMD	31.4	-	-34.95 %	$ 21.5 M	Germany
CRISPR Therapeutics AG CRSP	1.1 K	$ 49.8	-0.86 %	$ 4.48 B	Schweiz
Celyad Oncology SA CYAD	64.4	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	103	-	-7.31 %	$ 87 M	USA
Celldex Therapeutics CLDX	321	$ 31.27	4.37 %	$ 2.08 B	USA
Generation Bio Co. GBIO	47.6	-	-	$ 344 M	USA
IMV IMV	2.16 K	-	-	$ 13.1 M	Canada
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	3.66 K	-	-4.36 %	$ 27 M	USA
Anika Therapeutics ANIK	76.5	$ 14.72	-	$ 211 M	USA
Advaxis ADXS	3.28 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	126	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	28.1	$ 2.84	-0.35 %	$ 4.68 M	Israel
Esperion Therapeutics ESPR	99.7	$ 3.15	-	$ 655 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA